Ardea Biosciences | Evaluate

November 08, 2017

Selecta feels the pain of gout

Ironwood’s bargain might be a poisoned chalice

December 14, 2015

Horizon pays $500m for gout clout

August 13, 2014

Lesinurad data far from a crystal clear win for Astra

June 13, 2014

Upcoming events: Light for lesinurad and MLN9708 data

April 23, 2014

M&A buoys small caps but the action is elsewhere

February 07, 2013

M&A activity cools in 2012 as break-ups loom

January 22, 2013

Biotech still relying on friends for financing in 2012

August 28, 2012

Pascal Soriot answers AstraZeneca’s 911 call

July 26, 2012

Nasdaq biotech surge threatens to burn investors again

May 09, 2012

Negative adcom vote on Arcalyst puts gout approval in doubt

Load More